During the past decade, Institut de myologie conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut de myologie" #1 sponsor was "Institut de Myologie, France" with 4 trials, followed by "BioMarin Pharmaceutical" with 2 trials sponsored, "FibroGen" with 2 trials sponsored, "Assistance Publique Hopitaux De Marseille" with 1 trials sponsored and "Biogen" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut de myologie" #1 collaborator was "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator, "Association Française contre les Myopathies (AFM), Paris" with 1 trials as a collaborator, "Jain Foundation" with 1 trials as a collaborator and "Newcastle University" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Institut de myologie" are "Duchenne Muscular Dystrophy" (4 trials), "Neuromuscular Disorders" (2 trials), "Spinal Muscular Atrophy" (2 trials), "Centronuclear Myopathy" (1 trials) and "Distal Myopathy With Rimmed Vacuoles (DMRV)" (1 trials). Many other conditions were trialed in "Institut de myologie" in a lesser frequency.

Most popular intervention types in "Institut de myologie" are "Drug" (8 trials), "Device" (2 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Corticosteroids" (2 trials), "Pamrevlumab" (2 trials), "18F-FDG Positron emission tomography - MRI" (1 trials) and "ATYR1940" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut de myologie" are 11 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Institut de myologie". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Institut de myologie, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Institut de myologie, 4 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".